Gerresheimer, a systems and solutions provider for the pharmaceutical and cosmetics industries, is significantly expanding its production capacities for medical systems such as inhalers and auto-injectors in the US.
The expansion is in two stages and Gerresheimer is investing a total of approximately €166m (US$180m) in the construction and equipment for it.
The Germany-based company is expanding the production area at its Peachtree City site in the state of Georgia, USA, by around 194,000 sqft.
The Peachtree City site will have a total of approximately 130,000 sqft of cleanroom Class 8 and 9 production space
With the expansion in Peachtree, Gerresheimer is also underscoring its leading market position as a system and solution provider for drug delivery systems in the North American market.
Dietmar Siemssen, CEO of Gerresheimer, said: “North America is an important growth market for us. The expansion of the site in Peachtree City is of great importance for our medical device business in the USA. The expansion of this site is therefore currently one of the key projects in our global capacity expansions based on long-term customer contracts."
Construction work on the first expansion stage
Construction work of the first expansion stage is almost complete. A new building section covering around 83,000 sqft was built directly next to the existing plant.
A further 53,800 sqft, approximately, is intended for ISO 14644-1 cleanroom ISO Class 9 production areas.
53,800 sqft, approximately, is intended for ISO 14644-1 cleanroom class 9 production areas
After completion of the construction work, the installation of the specialised production technology will begin in the second half of 2024.
Also part of the new building is a new automated high-bay warehouse.
After completion of the first stage of expansion, the Peachtree City site will have a total of approximately 130,000 sqft of cleanroom ISO Class 8 and 9 production space.
The second stage of expansion: a new factory hall with a growth option
The second stage of expansion has already started and as part of the second stage Gerresheimer's manufacturing capabilities in Peachtree City, a new 110,000 sqft plant is being built near Atlanta Regional Airport, approximately 1.6 miles from the first production site.
The first production site will have an additional 77,500 sqft of cleanroom class 9 production space and also an automated high-bay warehouse.
In the course of 2025, the installation of the production and assembly lines will follow
After the preparatory work for the access road and supply infrastructure, the construction of the new factory building will soon begin at the Peachtree City production site.
In the course of 2025, the installation of the production and assembly lines will follow, and production is also scheduled to start at the Peachtreee City site towards the end of 2025.
The factory site on which the new building is being built also offers enough space for future expansions.
Gerresheimer is set to become one of the largest employers in the region
Gerresheimer will create more than 400 new jobs in Peachtree City as part of the expansion. The company currently employs around 270 people at the site.
The site will produce inhalers, components for infusion sets, microinjectors, test cards for microbiological tests and autoinjectors
Once the expansion is complete, Gerresheimer will be one of the largest employers in the city, which is located about 25 miles southwest of Atlanta, the capital of the state of Georgia, with around 700 employees.
At the Peachtree site, Gerresheimer produces medical devices such as inhalers, components for infusion sets, microinjectors, test cards for microbiological tests and autoinjectors, which can be used in diabetes and obesity therapy, among other things.
